Pharmacogenomics – testing a patient’s genetic makeup to guide safer, more effective medication choices and dosing – is not a new concept. But, like so many other clinical innovations, adoption has ...
Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...
KENILWORTH, N.J.--(BUSINESS WIRE)--With adverse drug events (ADEs) triggering an estimated 700,000 ED visits and 120,000 hospitalizations, RDx BioScience (RDx) points ...
- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - Capecitabine and 5-FU are used for the treatment of colorectal, esophageal, stomach, ...
STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York ...
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express™, a new, more focused report and set of ...
Susanne B. Haga ([email protected]) is an associate professor of medicine at the Duke University School of Medicine, in Durham, North Carolina. Ariel Kantor is an undergraduate research assistant at ...
Pharmacogenomics (PGx) testing is a powerful tool in the evolution of personalized medicine. However, for its full potential to be realized, labs must do more than just offer a scientifically sound ...
The struggles facing long-term care are numerous and well-documented. Providers, facilities, and families are constantly trying to find solutions to help improve patient care and staffing burdens.
Expert Rev Mol Diagn. 2012;12(8):841-855. From their experience with PGx testing, the authors believe that this clinical utility in primary care is possible. For instance, the authors recently ...
- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results